Production of interleukin (IL)-6 and IL-8 by a choriocarcinoma cell line, BeWo.
K Fujisawa, K Nasu, K Arima, T Sugano, H Narahara, I Miyakawa
Index: Placenta 21(4) , 354-60, (2000)
Full Text: HTML
Abstract
To clarify the biological and pathological features of choriocarcinoma, we evaluated the in vitro production of cytokines by a choriocarcinoma cell line, BeWo. We measured the concentration of interleukin (IL)-6 and IL-8 in the culture media of BeWo cells after stimulation with various modulatory agents of cytokine expression by enzyme-linked immunosorbent assays. Northern blot analysis was used to examine the expression of IL-6 and IL-8 mRNA in these cells. A weak expression of IL-6 and IL-8 was detected in unstimulated BeWo cells by both methods. IL-6 transcription and secretion were dose-dependently enhanced by stimulation with IL-1beta, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta1 and 12-O-tetradecanoyl phorbol-13-acetate (TPA). Forskolin, lipopolysaccharide and interferon-gamma had no effect on these cytokines production. The TNF-alpha-induced secretion of IL-6 was inhibited by dexamethasone. The TPA-induced production of IL-6 was inhibited by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine and sphyngosine, suggesting the involvement of a protein kinase C-dependent pathway. Levels of IL-8 mRNA and protein were also dose-dependently increased by stimulation with IL-1beta, TNF-alpha and TPA. In contrast to IL-6, the expression of IL-8 was not affected by TGF-beta1. It is suggested that, in addition to the production of steroidal and non-steroidal hormones, these cytokines may serve as part of a cytokine network that modulates the proliferation and angiogenesis of choriocarcinomas.Copyright 2000 Harcourt Publishers Ltd.
Related Compounds
Related Articles:
1999-01-01
[Endocrinology 140(1) , 29-36, (1999)]
1999-08-20
[Mol. Cell. Endocrinol. 154(1-2) , 89-100, (1999)]
Protein kinase C inhibition blocks the early appearance of vestibular compensation.
1999-10-16
[Brain Res. 845(1) , 97-101, (1999)]
1997-04-01
[Biol. Pharm. Bull. 20(4) , 446-8, (1997)]
1996-06-01
[Cell Biol. Toxicol. 12(3) , 177-85, (1996)]